naproxen has been researched along with sr 2640 in 1 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (sr 2640) | Trials (sr 2640) | Recent Studies (post-2010) (sr 2640) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 31 | 1 | 8 |
Protein | Taxonomy | naproxen (IC50) | sr 2640 (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 10 | |
Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 2 | |
Cysteinyl leukotriene receptor 1 | Cavia porcellus (domestic guinea pig) | 0.023 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 2 | |
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.023 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kreft, AF; Musser, JH | 1 |
1 review(s) available for naproxen and sr 2640
Article | Year |
---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |